Jeffrey A. Barnes

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells

Philipp Karschnia, Justin T. Jordan, Deborah Forst et al. · Blood · 2019 · 347 citations · Full text

Life Sciences, Immunology, Neurology +16

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma

Jeremy S. Abramson, Matthew D. Hellmann, Jeffrey A. Barnes et al. · Cancer · 2010 · 236 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Requirement of Mammalian <i>Timeless</i> for Circadian Rhythmicity

Jessica W. Barnes, Shelley A. Tischkau, Jeffrey A. Barnes et al. · Science · 2003 · 207 citations

Life Sciences, Genetics, Molecular Biology +17

T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai et al. · Journal of the National Comprehensive Cancer Network · 2022 · 167 citations · Full text

Medicine, Oncology, Pathology +15

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis

Jeffrey A. Barnes, Ann S. LaCasce, Yang Feng et al. · Annals of Oncology · 2011 · 149 citations · Full text

Medicine, Oncology, Pharmacotherapy +12